HCA Healthcare, Inc. $HCA Shares Acquired by Live Oak Private Wealth LLC

Live Oak Private Wealth LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,687 shares of the company’s stock after buying an additional 35 shares during the quarter. HCA Healthcare accounts for 2.0% of Live Oak Private Wealth LLC’s holdings, making the stock its 9th largest holding. Live Oak Private Wealth LLC’s holdings in HCA Healthcare were worth $13,672,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at $27,000. Ameriflex Group Inc. acquired a new stake in shares of HCA Healthcare in the second quarter valued at $27,000. Cheviot Value Management LLC purchased a new position in HCA Healthcare in the first quarter valued at $26,000. Saudi Central Bank purchased a new position in HCA Healthcare in the first quarter valued at $26,000. Finally, WPG Advisers LLC purchased a new position in HCA Healthcare in the first quarter valued at $27,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA opened at $468.21 on Thursday. The business’s 50-day simple moving average is $418.76 and its 200-day simple moving average is $385.09. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $475.38. The stock has a market capitalization of $109.56 billion, a P/E ratio of 18.10, a price-to-earnings-growth ratio of 1.37 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the firm earned $4.90 earnings per share. The business’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is 11.13%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on HCA shares. Oppenheimer lifted their target price on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a report on Monday. The Goldman Sachs Group lifted their target price on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday. Morgan Stanley set a $425.00 price target on HCA Healthcare in a report on Monday. Stephens lifted their price target on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday. Finally, TD Cowen lifted their price target on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a report on Monday. Fourteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $473.53.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.